On 2025-05-14, Citius Pharmaceuticals, Inc. (CTXR) announced earnings per share of $-1.27 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-1.08.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.76 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-1.08 | $-1.27 |
| 2025-02-14 | 2024-12-31 | $-1.25 | $-1.30 |
| 2024-08-12 | 2024-06-30 | $-1.25 | $-1.50 |
| 2024-05-14 | 2024-03-31 | $-1.50 | $-1.25 |
| 2024-02-14 | 2023-12-31 | $3.25 | $-1.50 |
| 2023-12-29 | 2023-09-30 | $-0.50 | $-1.75 |
| 2023-08-14 | 2023-06-30 | $-1.50 | $-1.50 |
| 2023-05-12 | 2023-03-31 | $-1.00 | $-1.75 |
| 2023-02-10 | 2022-12-31 | -- | $-1.00 |
| 2022-12-22 | 2022-09-30 | $-1.00 | $-1.25 |
| 2022-08-11 | 2022-06-30 | $-1.25 | $-1.50 |
| 2022-05-12 | 2022-03-31 | $-2.00 | $-1.25 |
| 2022-02-10 | 2021-12-31 | $-1.50 | $-1.50 |
| 2021-12-15 | 2021-09-30 | $-0.75 | $-0.75 |
| 2021-08-12 | 2021-06-30 | $-1.25 | $-1.25 |
| 2021-05-13 | 2021-03-31 | $-2.00 | $-1.00 |
| 2021-02-11 | 2020-12-31 | -- | $-3.75 |
| 2020-12-16 | 2020-09-30 | -- | $-1.75 |
| 2020-08-14 | 2020-06-30 | -- | $-2.75 |
| 2020-05-14 | 2020-03-31 | -- | $-3.25 |
| 2020-02-13 | 2019-12-31 | -- | $-3.75 |
| 2019-08-14 | 2019-06-30 | $-1.50 | $-5.00 |
| 2019-05-15 | 2019-03-31 | $-5.00 | $-5.00 |
| 2019-02-14 | 2018-12-31 | -- | $-5.50 |
| 2018-12-11 | 2018-09-30 | -- | $-4.50 |
| 2018-08-14 | 2018-06-30 | -- | $-4.75 |
| 2018-05-11 | 2018-03-31 | -- | $-11.00 |